The cardiovascular system is not a single failure point. It is a system — and it degrades across multiple mechanisms simultaneously. Lipid accumulation. Arterial inflammation. Clot formation. Mitochondrial decline in cardiac muscle. Calcium dysregulation. Blood pressure instability. Elevated homocysteine. Endothelial dysfunction.

A protocol that addresses only one of these is addressing one part of a multi-variable problem.

The stack below is built around that reality. Eight compounds, each targeting a different cardiovascular mechanism, all working on the same system at the same time. This is not a generic supplement list assembled from a wellness blog. It is a designed protocol with a specific physiological rationale behind every inclusion — and a clear understanding of how the mechanisms work together rather than in isolation.

Tadalafil: The Pharmacological Anchor

Tadalafil is best known as a PDE5 inhibitor — the mechanism behind its original indication. What is less widely understood is what PDE5 inhibition actually does physiologically and why it belongs at the center of a cardiovascular protocol.

PDE5 is an enzyme that breaks down cyclic GMP — the signaling molecule that triggers smooth muscle relaxation in arterial walls. When PDE5 is inhibited, cyclic GMP accumulates, smooth muscle relaxes, and blood vessels dilate. The immediate effect is improved blood flow. The downstream effect is reduced cardiac workload, improved oxygen delivery to cardiac and peripheral tissue, and a measurable reduction in arterial resistance.

The endothelial function story is where the cardiovascular case becomes compelling. The endothelium — the single-cell layer lining every blood vessel — is the primary regulator of vascular tone, inflammation, and the prevention of plaque formation. Endothelial dysfunction is one of the earliest and most consequential stages of cardiovascular disease progression. Tadalafil has documented effects on endothelial function that go beyond acute vasodilation — chronic low-dose use supports the nitric oxide signaling pathway that keeps the endothelium healthy and responsive.

Emerging research on cardiovascular outcomes with chronic low-dose tadalafil use is compelling enough that serious men’s health physicians are including it as a cardiovascular tool rather than just a sexual health one. The evidence base is still developing but the mechanistic rationale is sound. For men who are candidates — labs reviewed, health history considered, physician involved — it is the pharmacological layer the supplement stack below works alongside.

EPA/DHA (Omega-3 Fatty Acids): The Foundation

The most evidence-backed cardiovascular supplement available. The research base is deep, consistent, and spans decades across multiple large-scale clinical trials and meta-analyses.

EPA and DHA are the long-chain omega-3 fatty acids found in marine sources — the forms the body can use directly for cardiovascular benefit without the conversion step that makes plant-based omega-3s far less effective.

The cardiovascular mechanisms are multiple and distinct. Triglyceride reduction is the most well-established — EPA and DHA reduce hepatic triglyceride synthesis and increase clearance, with dose-dependent effects that become clinically meaningful at sufficient intake. For men with elevated triglycerides the effect can be significant.

The endothelial function benefit is separate from the lipid effect. EPA specifically reduces endothelial inflammation and supports the nitric oxide signaling that maintains vascular flexibility and tone — the same pathway tadalafil influences, approached from the nutritional angle. The anti-inflammatory mechanism operates through prostaglandin and leukotriene pathways, shifting the balance toward resolution of inflammation rather than its persistence.

One important practical note: dose matters and most men taking fish oil are significantly under-dosed. The cardiovascular evidence is built around meaningful EPA and DHA content — not total fish oil volume. A capsule containing 1000mg of fish oil may contain only 300mg of combined EPA and DHA. Read the label for actual EPA and DHA numbers. The total oil figure is largely irrelevant.

Nattokinase: The Fibrin Layer

Nattokinase is a fibrinolytic enzyme derived from natto — fermented soybeans — and it operates through a mechanism that is entirely distinct from every other compound in this stack. That distinction is exactly why it belongs here.

The fibrin network is the protein matrix involved in clot formation and arterial plaque progression. Fibrin provides the structural scaffolding that arterial plaques build on and that clots form around. Nattokinase degrades fibrin directly — breaking down existing fibrin structures and inhibiting the formation of new ones.

The evidence base includes meaningful data on blood flow improvement, reduction in platelet aggregation, and blood pressure reduction through nattokinase’s effects on angiotensin-converting enzyme — the same enzyme ACE inhibitor medications target. Multiple human trials have demonstrated cardiovascular benefit from consistent nattokinase supplementation.

Nattokinase is measured in Fibrinolytic Units rather than milligrams — the activity measure that determines actual potency. The number that matters on the label is the FU count, not the weight.

One important note: nattokinase should not be taken alongside prescription anticoagulants without medical oversight. The fibrinolytic activity is meaningful enough to compound the effects of blood-thinning medications.

Citrus Bergamot Extract: The Lipid Manager

Citrus bergamot extract is one of the most compelling natural lipid management compounds available — and one of the most underknown relative to the strength of its evidence base.

Consistent clinical trials have demonstrated meaningful reductions in LDL and triglycerides alongside improvements in HDL — effects that in some studies approach the magnitude of low-dose pharmaceutical lipid interventions. For men whose ApoB or LDL is elevated and who are not yet at the threshold for pharmaceutical management — or who want additional support alongside a pharmaceutical — bergamot offers a mechanism worth understanding.

The primary mechanism operates through HMG-CoA reductase inhibition — the same enzymatic pathway statins target. Bergamot also activates AMPK, an enzyme involved in cellular energy sensing and metabolic regulation, and improves insulin sensitivity as a downstream effect. The combination of mechanisms produces a broader metabolic benefit than lipid reduction alone.

The polyphenol content specific to bergamot — particularly bruteridin and melitidine — appears to be responsible for the primary lipid effects. Generic citrus extracts do not contain the same polyphenol profile. Bergamot extract specifically is the relevant compound.

Within the stack bergamot complements EPA/DHA in the lipid management layer without redundancy. Omega-3s primarily address triglycerides. Bergamot addresses LDL and the broader lipid panel including HDL. Two compounds, two different mechanisms, working on different parts of the same lipid problem simultaneously.

Ubiquinol (CoQ10): The Mitochondrial Layer

CoQ10 exists in two forms — ubiquinone and ubiquinol. Ubiquinol is the active, reduced form. The distinction matters because the conversion from ubiquinone to ubiquinol — which the body performs internally — declines meaningfully with age. Supplementing ubiquinol bypasses the conversion requirement and delivers the active form directly.

Cardiac muscle cells have some of the highest mitochondrial density and energy demands in the body. The heart contracts roughly 100,000 times per day without pause and the mitochondria that power those contractions require CoQ10 as a required cofactor in the electron transport chain — the process that produces ATP, the energy currency of cellular function. CoQ10 deficiency impairs cardiac energy production at the cellular level.

The cardiovascular evidence base is meaningful — data on heart failure outcomes, blood pressure reduction, and exercise capacity improvement all point to mitochondrial energy production as a cardiovascular variable worth optimizing. It is not a dramatic acute intervention. It is a foundational support for a system that runs continuously and whose function depends on mitochondrial health over time.

The statin connection deserves specific mention. Statins deplete CoQ10 through the same mevalonate pathway they use to reduce cholesterol synthesis. This is a well-established pharmacological consequence that most prescribing physicians do not discuss. Men on statin therapy are chronically depleting the cofactor their cardiac mitochondria depend on. Ubiquinol replacement is not optional in that context — it is basic maintenance of a system that the medication is inadvertently compromising.

For men not on statins ubiquinol remains a relevant cardiovascular investment and a compound with benefits extending to energy, cognitive function, and cellular health broadly.

Vitamin D3 + K2: The Calcium Director

D3 and K2 should not be discussed or supplemented separately in the context of cardiovascular health. They work synergistically — and taking D3 without K2 creates a calcium management problem that K2 specifically solves.

D3 drives calcium absorption from the gut. This is essential for bone health but creates a distribution question: where does the absorbed calcium go? Arterial calcification — the deposition of calcium in arterial walls — is one of the primary mechanisms of cardiovascular disease progression. Calcified arteries are stiff arteries. Stiff arteries mean elevated blood pressure, reduced cardiac efficiency, and accelerated atherosclerosis progression.

K2 — specifically the MK-7 form — activates matrix Gla-protein, the compound that directs calcium away from arterial walls and toward bone where it belongs. This is the mechanism that makes D3 + K2 a genuine cardiovascular protocol rather than just a bone health intervention. K2 is the traffic director that determines where the calcium D3 absorbed actually ends up.

Most men are deficient in both. D3 deficiency is near-universal in northern latitudes and increasingly common everywhere as modern indoor life reduces sun exposure. K2 is poorly represented in modern Western diets — found primarily in fermented foods and grass-fed animal products that most men are not eating consistently.

The combination supports cardiovascular function, bone density, immune function, testosterone production, and mood regulation simultaneously. One of the highest return supplement pairings available when viewed across the full range of mechanisms it touches.

Vitamin D is a marker worth testing — deficiency shows up in labs and supplementation response can be monitored directly. If labs have not included Vitamin D recently it is worth requesting specifically.

Magnesium Glycinate: The Regulatory Layer

Magnesium is involved in over 300 enzymatic reactions in the body. The cardiovascular-relevant ones include blood pressure regulation through arterial smooth muscle relaxation, cardiac rhythm stabilization, and endothelial function support. It is not a single-mechanism compound — it is a foundational mineral that the cardiovascular system depends on at multiple levels simultaneously.

Most men are deficient. Modern diets are consistently low in magnesium-rich foods and the deficiency is compounded by stress, alcohol consumption, and high carbohydrate intake — all of which deplete magnesium further. The majority of men who have not deliberately addressed magnesium intake are running below optimal levels without knowing it.

The form matters significantly. Magnesium oxide — the most common form in cheap supplements — is poorly absorbed and functions primarily as a laxative. Magnesium glycinate is the best-tolerated, highest-bioavailability form for systemic and cardiovascular benefit.

The blood pressure data is meaningful. Multiple meta-analyses show modest but consistent blood pressure reductions with magnesium supplementation in deficient individuals. Not a pharmaceutical intervention — a meaningful contribution to blood pressure management that works alongside lifestyle and the other compounds in this stack.

Cardiac rhythm is a specific application worth noting. Magnesium deficiency is associated with increased risk of arrhythmia — magnesium stabilizes the cardiac electrical conduction system. Men experiencing occasional palpitations or irregular rhythm episodes should address magnesium before pursuing more invasive investigation.

The glycinate chelation adds a secondary benefit independent of the cardiovascular effects. Glycine is an inhibitory neurotransmitter that supports GABA pathway function. Magnesium glycinate taken before sleep improves sleep quality through a mechanism entirely separate from its cardiovascular action — one compound with two high-value applications.

B Complex + Benfotiamine: The Homocysteine Layer

Elevated homocysteine is an independent cardiovascular risk factor — it damages arterial walls directly, promotes vascular inflammation, and accelerates atherosclerosis through mechanisms entirely distinct from lipid accumulation. A man can have a clean lipid panel and still be accumulating arterial damage from elevated homocysteine.

The primary nutritional intervention for elevated homocysteine is B vitamins — specifically B6, B12, and folate, which are the required cofactors for homocysteine metabolism. When these are deficient homocysteine accumulates. When they are adequate homocysteine is metabolized efficiently and cleared.

Men with MTHFR genetic variants — which impair the conversion of standard folate and B12 to their active methylated forms — are particularly susceptible to elevated homocysteine even with adequate B vitamin intake from diet. Methylated forms of B12 (methylcobalamin) and folate (methylfolate) bypass the conversion step and are the preferable forms for these men.

Benfotiamine is fat-soluble B1 — a form with significantly higher bioavailability than standard thiamine and with cardiovascular benefits that extend beyond homocysteine management. The primary additional mechanism is advanced glycation end-product reduction. AGEs are the cross-linking of proteins by glucose — a process that stiffens arterial walls, damages the endothelium, and contributes to the accelerated vascular aging that poor blood sugar management produces. Benfotiamine inhibits AGE formation through multiple biochemical pathways.

For men with elevated fasting glucose or HbA1c in their labs the AGE reduction mechanism makes benfotiamine directly relevant — connecting the metabolic and cardiovascular systems in a way that standard B vitamins alone do not address.

Homocysteine is one of the cardiovascular markers worth requesting specifically at the next lab draw. It is rarely included in standard panels and rarely ordered proactively. It is cheap to test and the intervention when elevated is straightforward.

How the Stack Works Together

Each compound in this stack was selected because it addresses a cardiovascular failure point that the others do not. There is no meaningful redundancy — the mechanisms are distinct and in most cases complementary.

The complete picture:

Tadalafil — endothelial function, vascular tone, nitric oxide signaling, cardiac workload reduction

EPA/DHA — triglyceride reduction, endothelial inflammation, anti-inflammatory prostaglandin balance

Nattokinase — fibrin network, clot formation, plaque structural progression

Citrus Bergamot — LDL reduction, HDL improvement, broader lipid panel management

Ubiquinol — cardiac mitochondrial energy production, electron transport chain support

D3 + K2 — calcium direction, arterial calcification prevention, vascular wall integrity

Magnesium Glycinate — blood pressure, cardiac rhythm, arterial smooth muscle, endothelial support

B Complex + Benfotiamine — homocysteine reduction, AGE formation inhibition, metabolic-cardiovascular bridge

No single compound covers the full picture. A man taking only fish oil is addressing triglycerides and endothelial inflammation while leaving lipid management, fibrin, mitochondrial function, calcium metabolism, blood pressure, and homocysteine unaddressed. A man taking only a statin is addressing LDL while potentially depleting the CoQ10 his cardiac mitochondria depend on. A complete protocol requires intentional coverage of multiple mechanisms simultaneously.

This stack is that coverage. Not assembled from a wellness list. Built around the specific mechanisms through which the cardiovascular system degrades — and the specific evidence-based interventions that address each one.

The Tempered Position

The cardiovascular system does not fail at one point. It degrades quietly, across multiple mechanisms, often for years or decades before anything becomes clinically obvious. The first symptom for a significant percentage of men is the cardiac event itself.

The men who address these mechanisms proactively — with compounds that have real evidence behind them, for reasons they understand, monitored with regular labs — are investing in a system that has no backup. The heart does not get a rest day. It does not recover from neglect the way muscle does. It either functions or it doesn’t.

Treat it accordingly. Get the labs. Build the stack. Monitor the response. Do not wait for a symptom that may not arrive until it is too late to act on.

The cardiovascular framework — including lab markers worth tracking and the tadalafil protocol — is covered in depth in the Field Manual. thetemperedman.com